Tuesday, September 27, 2016

French company gets U.S. dollars to fight a South American disease


Sept 26 (Reuters) - French drug company Sanofi SA said on Monday the U.S. Department of Health and Human Services approved $43.18 million of your tax dollars to fund accelerating the development of a Zika vaccine.

The funding runs through June 2022, but if the data is positive, the contract includes an option for up to additional $130.45 million for late-stage trials necessary for eventual approval. [Read more…]

Businesses used to say, "Find a need and fill it." Now, the modus operandi of successful businesses seems to be "Create a need and fill it..."

Note: This page does NOT use Google Adsense. All the sponsors were personally selected by me. Please continue to support this page by clicking on the ads. To see other products I endorse, click here. 
To return to the home page, click here 


 Bill K. Underwood is a freelance columnist and author of several books, including two novels - The Minotaur Medallion, and the best-selling Resurrection Day. Both are available in paperback here


2 comments:

  1. Argentina did a study. They concluded the birth defects attributed to Zika is actually caused by chemicals added to drinking water in Brazil.

    ReplyDelete
  2. Exactly. Caused by the chemicals sprayed, yet let's go ahead push the vaccines. This is a sick, sick world. Men ruining the earth.

    ReplyDelete